Harrison & Co Wealth Management LLC Raises Holdings in Johnson & Johnson (NYSE:JNJ)

Harrison & Co Wealth Management LLC boosted its stake in shares of Johnson & Johnson (NYSE:JNJGet Rating) by 1.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,625 shares of the company’s stock after purchasing an additional 95 shares during the quarter. Harrison & Co Wealth Management LLC’s holdings in Johnson & Johnson were worth $998,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of JNJ. Kayne Anderson Rudnick Investment Management LLC increased its holdings in Johnson & Johnson by 0.3% during the 4th quarter. Kayne Anderson Rudnick Investment Management LLC now owns 129,485 shares of the company’s stock worth $22,153,000 after purchasing an additional 350 shares during the period. Mutual Advisors LLC boosted its position in shares of Johnson & Johnson by 2.9% during the 4th quarter. Mutual Advisors LLC now owns 47,197 shares of the company’s stock worth $8,074,000 after acquiring an additional 1,320 shares in the last quarter. Trail Ridge Investment Advisors LLC acquired a new position in shares of Johnson & Johnson during the 4th quarter worth about $1,524,000. Nissay Asset Management Corp Japan ADV boosted its position in shares of Johnson & Johnson by 5.0% during the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 346,023 shares of the company’s stock worth $59,194,000 after acquiring an additional 16,587 shares in the last quarter. Finally, Fort Point Capital Partners LLC boosted its position in shares of Johnson & Johnson by 16.1% during the 4th quarter. Fort Point Capital Partners LLC now owns 4,360 shares of the company’s stock worth $746,000 after acquiring an additional 605 shares in the last quarter. Hedge funds and other institutional investors own 68.59% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on JNJ shares. Wells Fargo & Company upped their price objective on Johnson & Johnson from $190.00 to $195.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 13th. Morgan Stanley decreased their target price on Johnson & Johnson from $174.00 to $173.00 and set an “equal weight” rating for the company in a research report on Monday, September 12th. UBS Group decreased their target price on Johnson & Johnson from $185.00 to $180.00 in a research report on Thursday, July 21st. Daiwa Capital Markets initiated coverage on Johnson & Johnson in a research report on Wednesday, June 22nd. They issued an “outperform” rating for the company. Finally, Citigroup decreased their target price on Johnson & Johnson from $205.00 to $201.00 in a research report on Wednesday, July 20th. Four research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Johnson & Johnson currently has an average rating of “Moderate Buy” and an average target price of $189.78.

Johnson & Johnson Stock Down 0.8 %

Johnson & Johnson stock opened at $164.97 on Wednesday. Johnson & Johnson has a twelve month low of $155.72 and a twelve month high of $186.69. The stock has a 50 day moving average of $168.71 and a two-hundred day moving average of $174.30. The company has a current ratio of 1.42, a quick ratio of 1.17 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $433.74 billion, a price-to-earnings ratio of 24.01, a PEG ratio of 2.97 and a beta of 0.61.

Johnson & Johnson (NYSE:JNJGet Rating) last posted its quarterly earnings data on Tuesday, July 19th. The company reported $2.59 earnings per share for the quarter, topping analysts’ consensus estimates of $2.57 by $0.02. Johnson & Johnson had a return on equity of 36.14% and a net margin of 19.21%. The company had revenue of $24.02 billion during the quarter, compared to analysts’ expectations of $23.85 billion. During the same period last year, the firm earned $2.48 EPS. The firm’s revenue for the quarter was up 3.0% on a year-over-year basis. As a group, research analysts expect that Johnson & Johnson will post 10.7 earnings per share for the current year.

Johnson & Johnson Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 6th. Stockholders of record on Tuesday, August 23rd were paid a dividend of $1.13 per share. This represents a $4.52 dividend on an annualized basis and a dividend yield of 2.74%. The ex-dividend date was Monday, August 22nd. Johnson & Johnson’s dividend payout ratio (DPR) is 65.79%.

Johnson & Johnson declared that its Board of Directors has initiated a share repurchase program on Wednesday, September 14th that allows the company to buyback $5.00 billion in shares. This buyback authorization allows the company to repurchase up to 1.2% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s management believes its stock is undervalued.

Johnson & Johnson Company Profile

(Get Rating)

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR.

Read More

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.